MF59-adjuvanted trivalent seasonal influenza vaccine compared to high-dose trivalent seasonal influenza vaccine among older adults, a systematic literature review

被引：0
|
作者：
Dang, J. [1 ]
McGovern, I. [1 ]
Haag, M. [1 ]
Coleman, B. [2 ]
机构：
[1] CSL Seqirus, Summit, NJ USA
[2] Univ Toronto, Publ Hlth, Toronto, ON, Canada
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2023年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
A81
引用
收藏
页码：S42 / S43
页数：2
相关论文
共 50 条
  • [1] Effectiveness of the MF59-adjuvanted trivalent seasonal influenza vaccine among adults aged 65 or older; a systematic review and meta-analysis
    Kennedy, Alex
    Sanderson, Ruth
    McGovern, Ian
    Haag, Mendel
    AUSTRALASIAN JOURNAL ON AGEING, 2021, 40 : 67 - 68
  • [2] Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children
    Patel, Sanjay S.
    Bizjajeva, Svetlana
    Lindert, Kelly
    Heijnen, Esther
    Oberye, Janine
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 85 : S26 - S38
  • [3] Effectiveness of the MF59-adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta-analysis
    Coleman, Brenda L.
    Sanderson, Ruth
    Haag, Mendel D. M.
    McGovern, Ian
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2021, 15 (06) : 813 - 823
  • [4] MF59-adjuvanted seasonal trivalent inactivated influenza vaccine: Safety and immunogenicity in young children at risk of influenza complications
    Patel, Sanjay S.
    Bizjajeva, Svetlana
    Heijnen, Esther
    Oberye, Janine
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 85 : S18 - S25
  • [5] Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children and adults 65 years of age and older
    Lindert, Kelly
    Leav, Brett
    Heijnen, Esther
    Barrett, Julia
    Nicolay, Uwe
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 85 : S10 - S17
  • [6] Cost-effectiveness of introducing an MF59-adjuvanted trivalent influenza vaccine for older adults in Argentina
    Van Hung Nguyen
    Vizzotti, Carla
    Uruena, Analia
    Giglio, Norberto
    Magneres, Cecilia
    Richmond, Heather
    VACCINE, 2020, 38 (20) : 3682 - 3689
  • [7] Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults
    Essink, Brandon
    Fierro, Carlos
    Rosen, Jeffrey
    Figueroa, Amparo L.
    Zhang, Bin
    Verhoeven, Carole
    Edelman, Jonathan
    Smolenov, Igor
    VACCINE, 2020, 38 (02) : 242 - 250
  • [8] Additional Burden Averted in the United States From Use of MF59-Adjuvanted Seasonal Influenza Vaccine Compared With Standard Seasonal Influenza Vaccine Among Adults ≥65 Years
    McGovern, Ian
    Sardesai, Aditya
    Taylor, Alexandra
    Toro-Diaz, Hector
    Haag, Mendel
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (08):
  • [9] Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis
    Domnich, Alexander
    Arata, Lucia
    Amicizia, Daniela
    Puig-Barbera, Joan
    Gasparini, Roberto
    Panatto, Donatella
    VACCINE, 2017, 35 (04) : 513 - 520
  • [10] Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults
    Li, Athena P. Y.
    Cohen, Carolyn A.
    Leung, Nancy H. L.
    Fang, Vicky J.
    Gangappa, Shivaprakash
    Sambhara, Suryaprakash
    Levine, Min Z.
    Iuliano, A. Danielle
    Perera, Ranawaka A. P. M.
    Ip, Dennis K. M.
    Peiris, J. S. Malik
    Thompson, Mark G.
    Cowling, Benjamin J.
    Valkenburg, Sophie A.
    NPJ VACCINES, 2021, 6 (01)
12345